Expression of microRNAs miR21, miR146a, and miR155 in tuberous sclerosis complex cortical tubers and their regulation in human astrocytes and SEGA-derived cell cultures

GLIA

Volumn 64, Issue 6, 2016, Pages 1066-1082

  van Scheppingen, J ^a   Iyer, A M ^a   Prabowo, A S ^a   Muhlebner A ^a,b   Anink, J J ^a   Scholl, T ^b   Feucht, M ^b   Jansen, F E ^c   Spliet, W G ^c   Krsek, P ^d   Zamecnik, J ^d   Buccoliero, A M ^e   Giordano, F ^e   Genitori, L ^e   Kotulska, K ^f   Jozwiak, S ^g   Jaworski, J ^h   Liszewska, E ^h   van Vliet, E A ^a   Aronica, E ^a,i,j  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^e UNIVERSITY OF FLORENCE   (Italy)

^f CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^g MEDICAL UNIVERSITY OF WARSAW   (Poland)

^h INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

ⁱ UNIVERSITY OF AMSTERDAM   (Netherlands)

^j STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

more..

Author keywords

Astrocytes; Cultures; Inflammation; MicroRNA; Subependymal giant cell astrocytoma; Tuberous sclerosis complex

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MICRORNA 146A; MICRORNA 155; MICRORNA 21; MICRORNA; MIRN146 MICRORNA, HUMAN; MIRN155 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN;

ADOLESCENT; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; BRAIN TISSUE; CELL VIABILITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FETUS; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; GIANT CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SUBEPENDYMAL GIANT CELL ASTROCYTOMA; TUBEROUS SCLEROSIS; ASTROCYTOMA; BRAIN; CELL CULTURE; CELL CULTURE TECHNIQUE; INFANT; METABOLISM; MIDDLE AGED; NERVE CELL; PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; ASTROCYTES; ASTROCYTOMA; BRAIN; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MICRORNAS; MIDDLE AGED; NEURONS; SIGNAL TRANSDUCTION; TUBEROUS SCLEROSIS; YOUNG ADULT;

EID: 84961658261     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22983     Document Type: Article

References (101)

1. Aronica E, Becker AJ, Spreafico R. 2012a. Malformations of cortical development. Brain Pathol 22:380-401.
2. Aronica E, Crino PB. 2011. Inflammation in epilepsy: Clinical observations. Epilepsia 52 (Suppl 3):26-32.
3. Aronica E, Crino PB. 2014. Epilepsy related to developmental tumors and malformations of cortical development. Neurotherapeutics 11:251-268.
4. Aronica E, Fluiter K, Iyer A, Zurolo E, Vreijling J, van Vliet EA, Baayen JC, Gorter JA. 2010. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci 31:1100-1107.
5. Aronica E, Gorter JA, Ijlst-Keizers H, Rozemuller AJ, Yankaya B, Leenstra S, Troost D. 2003. Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: Opposite regulation of glutamate transporter proteins. Eur J Neurosci 17:2106-2118.
6. Aronica E, Gorter JA, Rozemuller AJ, Yankaya B, Troost D. 2005. Interleukin-1 beta down-regulates the expression of metabotropic glutamate receptor 5 in cultured human astrocytes. J Neuroimmunol 160:188-194.
7. Aronica E, Ravizza T, Zurolo E, Vezzani A. 2012b. Astrocyte immune responses in epilepsy. Glia 60:1258-1268.
8. Bartfai T, Sanchez-Alavez M, Andell-Jonsson S, Schultzberg M, Vezzani A, Danielsson E, Conti B. 2007. Interleukin-1 system in CNS stress: Seizures, fever, and neurotrauma. Ann NY Acad Sci 1113:173-177.
9. Bhalala OG, Pan L, Sahni V, McGuire TL, Gruner K, Tourtellotte WG, Kessler JA. 2012. microRNA-21 regulates astrocytic response following spinal cord injury. J Neurosci 32:17935-17947.
10. Bockaert J, Marin P. 2015. mTOR in brain physiology and pathologies. Physiol Rev 95:1157-1187.
11. Boer K, Crino PB, Gorter JA, Nellist M, Jansen FE, Spliet WG, van Rijen PC, Wittink FR, Breit TM, Troost D, Wadman WJ, Aronica E. 2010. Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors. Brain Pathol 20:704-719.
12. Boer K, Jansen F, Nellist M, Redeker S, van den Ouweland AM, Spliet WG, van Nieuwenhuizen O, Troost D, Crino PB, Aronica E. 2008. Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res 78:7-21.
13. Buller B, Liu X, Wang X, Zhang RL, Zhang L, Hozeska-Solgot A, Chopp M, Zhang ZG. 2010. MicroRNA-21 protects neurons from ischemic death. FEBS J 277:4299-4307.
14. Carson RP, Van Nielen DL, Winzenburger PA, Ess KC. 2012. Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin. Neurobiol Dis 45:369-380.
15. Chen X, Liang H, Zhang J, Zen K, Zhang CY. 2012. Secreted microRNAs: A new form of intercellular communication. Trends Cell Biol 22:125-132.
16. Chew LJ, Takanohashi A, Bell M. 2006. Microglia and inflammation: Impact on developmental brain injuries. Ment Retard Dev Disabil Res Rev 12:105-112.
17. Cohly HH, Panja A. 2005. Immunological findings in autism. Int Rev Neurobiol 71:317-341.
18. Cui JG, Li YY, Zhao Y, Bhattacharjee S, Lukiw WJ. 2010. Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease. J Biol Chem 285:38951-38960.
19. Curatolo P, Aronica E, Jansen A, Jansen F, Kotulska K, Lagae L, Moavero R, Jozwiak S. 2016. Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC. Eur J Paediatr Neurol 20:203-211.
20. Curatolo P, Moavero R, de Vries PJ. 2015. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol 14:733-745.
21. Desjardins P, Sauvageau A, Bouthillier A, Navarro D, Hazell AS, Rose C, Butterworth RF. 2003. Induction of astrocytic cyclooxygenase-2 in epileptic patients with hippocampal sclerosis. Neurochem Int 42:299-303.
22. DiMario FJ Jr, Sahin M, Ebrahimi-Fakhari D. 2015. Tuberous sclerosis complex. Pediatr Clin North Am 62:633-648.
23. DiMario FJ Jr. 2004. Brain abnormalities in tuberous sclerosis complex. J Child Neurol 19:650-657.
24. Elton TS, Selemon H, Elton SM, Parinandi NL. 2013. Regulation of the MIR155 host gene in physiological and pathological processes. Gene 532:1-12.
25. Gorter JA, van Vliet EA, Aronica E, Breit T, Rauwerda H, LopesdaSilva FH, Wadman WJ. 2006. Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J Neurosci 26:11083-11110.
26. Gorter JA, Iyer A, White I, Colzi A, van Vliet EA, Sisodiya S, Aronica E. 2014. Hippocampal subregion-specific microRNA expression during epileptogenesis in experimental temporal lobe epilepsy. Neurobiol Dis 62:508-520.
27. Ha TY. 2011. MicroRNAs in human diseases: From cancer to cardiovascular disease. Immune Netw 11:135-154.
28. Harter DH, Bassani L, Rodgers SD, Roth J, Devinsky O, Carlson C, Wisoff JH, Weiner HL. 2014. A management strategy for intraventricular subependymal giant cell astrocytomas in tuberous sclerosis complex. J Neurosurg Pediatr 13:21-28.
29. He X, Jing Z, Cheng G. 2014. MicroRNAs: New regulators of Toll-like receptor signalling pathways. Biomed Res Int 2014:945169.
30. Henshall DC. 2013. MicroRNAs in the pathophysiology and treatment of status epilepticus. Front Mol Neurosci 6:37.
31. Iori V, Iyer A, Aronica E, Vezzani A. 2013. microRNA146a-mediated epigenetic control of brain inflammation: New therapeutic opportunities in epilepsy. In 30th International Epilepsy Congress, Montreal, Canada.
32. Iyer A, Zurolo E, Prabowo A, Fluiter K, Spliet WG, van Rijen PC, Gorter JA, Aronica E. 2012. MicroRNA-146a: A key regulator of astrocyte-mediated inflammatory response. PloS One 7:e44789.
33. Jin XF, Wu N, Wang L, Li J. 2013. Circulating microRNAs: A novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases. Cell Mol Neurobiol 33:601-613.
34. Kan AA, van Erp S, Derijck AA, de Wit M, Hessel EV, O'Duibhir E, de Jager W, Van Rijen PC, Gosselaar PH, de Graan PN, Pasterkamp RJ. 2012. Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune response. Cell Mol Life Sci 69:3127-3145.
35. Khan AA, Betel D, Miller ML, Sander C, Leslie CS, Marks DS. 2009. Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat Biotechnol 27:549-555.
36. Kong W, He L, Richards EJ, Challa S, Xu CX, Permuth-Wey J, Lancaster JM, Coppola D, Sellers TA, Djeu JY, Cheng JQ. 2014. Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer. Oncogene 33:679-689.
37. Krichevsky AM, Gabriely G. 2009. miR-21: A small multi-faceted RNA. J Cell Mol Med 13:39-53.
38. Kumarswamy R, Volkmann I, Thum T. 2011. Regulation and function of miRNA-21 in health and disease. RNA Biol 8:706-713.
39. Lee JY, Park AK, Lee ES, Park WY, Park SH, Choi JW, Phi JH, Wang KC, Kim SK. 2014. miRNA expression analysis in cortical dysplasia: Regulation of mTOR and LIS1 pathway. Epilepsy Res 108:433-441.
40. Lehmann SM, Kruger C, Park B, Derkow K, Rosenberger K, Baumgart J, Trimbuch T, Eom G, Hinz M, Kaul D, Habbel P, Kälin R, Franzoni E, Rybak A, Nguyen D, Veh R, Ninnemann O, Peters O, Nitsch R, Heppner FL, Golenbock D, Schott E, Ploegh HL, Wulczyn FG, Lehnardt S. 2012. An unconventional role for miRNA: Let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci 15:827-835.
41. Li L, Chen XP, Li YJ. 2010. MicroRNA-146a and human disease. Scand J Immunol 71:227-231.
42. Li MM, Li XM, Zheng XP, Yu JT, Tan L. 2014. MicroRNAs dysregulation in epilepsy. Brain Res 1584:94-104.
43. Liang XH, Hart CE, Crooke ST. 2013. Transfection of siRNAs can alter miRNA levels and trigger non-specific protein degradation in mammalian cells. Biochim Biophys Acta 1829:455-468.
44. Lim HK, Choi YA, Park W, Lee T, Ryu SH, Kim SY, Kim JR, Kim JH, Baek SH. 2003. Phosphatidic acid regulates systemic inflammatory responses by modulating the Akt-mammalian target of rapamycin-p70 S6 kinase 1 pathway. J Biol Chem 278:45117-45127.
45. Lopez-Ramirez MA, Wu D, Pryce G, Simpson JE, Reijerkerk A, King-Robson J, Kay O, de Vries HE, Hirst MC, Sharrack B, Baker D, Male DK, Michael GJ, Romero IA. 2014. MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation. FASEB J 28:2551-2565.
46. Lukiw WJ, Surjyadipta B, Dua P, Alexandrov PN. 2012. Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD). Int J Biochem Mol Biol 3:105-116.
47. Lukiw WJ, Zhao Y, Cui JG. 2008. An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem 283:31315-31322.
48. Malik AR, Liszewska E, Skalecka A, Urbanska M, Iyer AM, Swiech LJ, Perycz M, Parobczak K, Pietruszka P, Zarebska MM, Macias M, Kotulska K, Borkowska J, Grajkowska W, Tyburczy ME, Jozwiak S, Kwiatkowski DJ, Aronica E, Jaworski J. 2015. Tuberous sclerosis complex neuropathology requires glutamate-cysteine ligase. Acta Neuropathol Commun 3:48.
49. Maroso M, Balosso S, Ravizza T, Liu J, Bianchi ME, Vezzani A. 2011. Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: The importance of IL-1beta and high-mobility group box 1. J Intern Med 270:319-326.
50. Mei J, Bachoo R, Zhang CL. 2011. MicroRNA-146a inhibits glioma development by targeting Notch1. Mol Cell Biol 31:3584-3592.
51. Mizuguchi M, Takashima S. 2001. Neuropathology of tuberous sclerosis. Brain Dev 23:508-515.
52. Moffett HF, Novina CD. 2007. A small RNA makes a Bic difference. Genome Biol 8:221.
53. Moore LM, Zhang W. 2010. Targeting miR-21 in glioma: A small RNA with big potential. Expert Opin Ther Targets 14:1247-1257.
54. Natsume A, Kinjo S, Yuki K, Kato T, Ohno M, Motomura K, Iwami K, Wakabayashi T. 2011. Glioma-initiating cells and molecular pathology: Implications for therapy. Brain Tumor Pathol 28:1-12.
55. Noriega DB, Savelkoul HF. 2014. Immune dysregulation in autism spectrum disorder. Eur J Pediatr 173:33-43.
56. O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D. 2009. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci USA 106:7113-7118.
57. O'Connell RM, Rao DS, Baltimore D. 2012. microRNA regulation of inflammatory responses. Annu Rev Immunol 30:295-312.
58. O'Neill LA, Sheedy FJ, McCoy CE. 2011. MicroRNAs: The fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 11:163-175.
59. Omran A, Peng J, Zhang C, Xiang QL, Xue J, Gan N, Kong H, Yin F. 2012. Interleukin-1beta and microRNA-146a in an immature rat model and children with mesial temporal lobe epilepsy. Epilepsia 53:1215-1224.
60. Orlova KA, Crino PB. 2010. The tuberous sclerosis complex. Ann NY Acad Sci 1184:87-105.
61. Ouyang T, Zhang N, Benjamin T, Wang L, Jiao J, Zhao Y, Chen J. 2014. Subependymal giant cell astrocytoma: Current concepts, management, and future directions. Childs Nerv Syst 30:561-570.
62. Prabowo AS, Anink JJ, Lammens M, Nellist M, van den Ouweland AM, Adle-Biassette H, Sarnat HB, Flores-Sarnat L, Crino PB, Aronica E. 2013. Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation. Brain Pathol 23:45-59.
63. Prabowo AS, van Scheppingen J, Iyer AM, Anink JJ, Spliet WG, van Rijen PC, Schouten-van Meeteren AY, Aronica E. 2015. Differential expression and clinical significance of three inflammation-related microRNAs in gangliogliomas. J Neuroinflammation 12:97.
64. Quinn SR, O'Neill LA. 2011. A trio of microRNAs that control Toll-like receptor signalling. Int Immunol 23:421-425.
65. Ramakers C, Ruijter JM, Deprez RH, Moorman AF. 2003. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 339:62-66.
66. Rao P, Benito E, Fischer A. 2013. MicroRNAs as biomarkers for CNS disease. Front Mol Neurosci 6:39.
67. Rao VT, Ludwin SK, Fuh SC, Sawaya R, Moore CS, Ho MK, Bedell BJ, Sarnat HB, Bar-Or A, Antel JP. MicroRNA expression patterns in human astrocytes in relation to anatomical location and age. J Neuropathol Exp Neurol, in press.
68. Ravizza T, Boer K, Redeker S, Spliet WG, van Rijen PC, Troost D, Vezzani A, Aronica E. 2006. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis 24:128-143.
69. Ravizza T, Iori V, Iyer AM, Aronica E, Vezzani A. 2013. miR146a-mediated control of brain inflammation: A new therapeutic opportunity in epilepsy. American Epilepsy Society 2013 Annual Meeting aC ed., Washington, D.C.
70. Reus GZ, Fries GR, Stertz L, Badawy M, Passos IC, Barichello T, Kapczinski F, Quevedo J. 2015. The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience 300:141-154.
71. Ruijter JM, Ramakers C, Hoogaars WM, Karlen Y, Bakker O, van den Hoff MJ, Moorman AF. 2009. Amplification efficiency: Linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res 37:e45.
72. Ruppe V, Dilsiz P, Reiss CS, Carlson C, Devinsky O, Zagzag D, Weiner HL, Talos DM. 2014. Developmental brain abnormalities in tuberous sclerosis complex: A comparative tissue analysis of cortical tubers and perituberal cortex. Epilepsia 55:539-550.
73. Schmitz F, Heit A, Dreher S, Eisenacher K, Mages J, Haas T, Krug A, Janssen KP, Kirschning CJ, Wagner H. 2008. Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. Eur J Immunol 38:2981-2992.
74. Sethi P, Lukiw WJ. 2009. Micro-RNA abundance and stability in human brain: Specific alterations in Alzheimer's disease temporal lobe neocortex. Neuroscience Letters 459:100-104.
75. Sheedy FJ, O'Neill LA. 2008. Adding fuel to fire: micrornas as a new class of mediators of inflammation. Ann Rheum Dis 67 (Suppl 3):iii50-55.
76. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q, Johnson DS, Chen Y, O'Neill LA. 2010. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 11:141-147.
77. Soliman GA. 2013. The role of mechanistic target of rapamycin (mTOR) complexes signaling in the immune responses. Nutrients 5:2231-2257.
78. Sosunov AA, Wu X, Weiner HL, Mikell CB, Goodman RR, Crino PD, McKhann GM II. 2008. Tuberous sclerosis: A primary pathology of astrocytes? Epilepsia 49 (Suppl 2):53-62.
79. Sosunov AA, McGovern RA, Mikell CB, Wu X, Coughlin DG, Crino PB, Weiner HL, Ghatan S, Goldman JE, McKhann GM 2nd. 2015. Epileptogenic but MRI-normal perituberal tissue in Tuberous Sclerosis Complex contains tuber-specific abnormalities Acta Neuropathol Commun 3:17.
80. Staszel T, Zapala B, Polus A, Sadakierska-Chudy A, Kiec-Wilk B, Stepien E, Wybranska I, Chojnacka M, Dembinska-Kiec A. 2011. Role of microRNAs in endothelial cell pathophysiology. Pol Arch Med Wewn 121:361-366.
81. Taganov KD, Boldin MP, Chang KJ, Baltimore D. 2006. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103:12481-12486.
82. Tarassishin L, Lee SC. 2013. Interferon regulatory factor 3 alters glioma inflammatory and invasive properties. J Neurooncol 113:185-194.
83. Tarassishin L, Loudig O, Bauman A, Shafit-Zagardo B, Suh HS, Lee SC. 2011. Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155*. Glia 59:1911-1922.
84. The European Chromosome 16 Tuberous Sclerosis Consortium. 1993. ECTS C: Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305-1315.
85. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, Croce CM. 2007. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179:5082-5089.
86. Tili E, Michaille JJ, Croce CM. 2013. MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer. Immunol Rev 253:167-184.
87. van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A, Halley D, Young J, Burley M, Jeremiah S, Woodward K, Nahmias J, Fox M, Ekong R, Osborne J, Wolfe J, Povey S, Snell RG, Cheadle JP, Jones AC, Tachataki M, Ravine D, Sampson JR, Reeve MP, Richardson P, Wilmer F, Munro C, Hawkins TL, Sepp T, Ali JB, Ward S, Green AJ, Yates JR, Kwiatkowska J, Henske EP, Short MP, Haines JH, Jozwiak S, Kwiatkowski DJ. 1997. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805-808.
88. Vezzani A, Aronica E, Mazarati A, Pittman QJ. 2013a. Epilepsy and brain inflammation. Exp Neurol 244:11-21.
89. Vezzani A, Friedman A, Dingledine RJ. 2013b. The role of inflammation in epileptogenesis. Neuropharmacology 69:16-24.
90. Vezzani A, Maroso M, Balosso S, Sanchez MA, Bartfai T. 2011. IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immunity 25:1281-1289.
91. Wan G, Xie W, Liu Z, Xu W, Lao Y, Huang N, Cui K, Liao M, He J, Jiang Y, Yang BB, Xu H, Xu N, Zhang Y. 2014. Hypoxia-induced MIR155 is a potent autophagy inducer by targeting multiple players in the MTOR pathway. Autophagy 10:70-79.
92. Wang J, Tan L, Tan L, Tian Y, Ma J, Tan CC, Wang HF, Liu Y, Tan MS, Jiang T, Yu JT. 2015a. Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy. Sci Rep 5:10201.
93. Wang J, Yu JT, Tan L, Tian Y, Ma J, Tan CC, Wang HF, Liu Y, Tan MS, Jiang T, Tan L. 2015b. Genome-wide circulating microRNA expression profiling indicates biomarkers for epilepsy. Sci Rep 5:9522.
94. Weichhart T, Saemann MD. 2009. The multiple facets of mTOR in immunity. Trends Immunol 30:218-226.
95. Wong M, Crino PB. 2012. Tuberous sclerosis and epilepsy: Role of astrocytes. Glia 60:1244-1250.
96. Woodbury ME, Freilich RW, Cheng CJ, Asai H, Ikezu S, Boucher JD, Slack F, Ikezu T. 2015. miR-155 is essential for inflammation-induced hippocampal neurogenic dysfunction. J Neurosci 35:9764-9781.
97. Wu XY, Fan WD, Fang R, Wu GF. 2014. Regulation of microRNA-155 in endothelial inflammation by targeting nuclear factor (NF)-kappaB P65. J Cell Biochem 115:1928-1936.
98. Zhang B, Zou J, Rensing NR, Yang M, Wong M. 2015. Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex. Neurobiol Dis 80:70-79.
99. Zhang L, Dong LY, Li YJ, Hong Z, Wei WS. 2012. miR-21 represses FasL in microglia and protects against microglia-mediated neuronal cell death following hypoxia/ischemia. Glia 60:1888-1895.
100. Zhang Q, Xu J, Chen Q, Chen X, Zen K, Zhang CY. 2013. Selective secretion of microRNA in CNS system. Protein Cell 4:243-247.
101. Zurolo E, Iyer A, Maroso M, Carbonell C, Anink JJ, Ravizza T, Fluiter K, Spliet WG, van Rijen PC, Vezzani A, Aronica E. 2011. Activation of toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development. Brain 134:1015-1032.